Abstract:Mutations in the BRCA1 or BRCA2 genes predispose to a wide spectrum of familial cancers. The functions of the proteins encoded by BRCA1 and BRCA2 remain to be elucidated, but their interaction and colocalization with hRAD51 suggest a role in homologous recombination and DNA double-strand break (DSB) repair. The role of BRCA1 and BRCA2 in the rejoining of ionizing radiation (IR)-induced DNA DSBs, which may represent a step in the overall process of repair, remains uncertain because recent reports provide conflicting results. Because elucidation of the role of these proteins in DNA DSB rejoining is important for their functional characterization, we reexamined this end point in cells with mutations in either BRCA1 or BRCA2. We show that two pancreatic carcinoma cell lines known to have either wild-type (BxPC3) or mutant forms (Capan-1) of BRCA2 rejoin IR-induced DNA DSBs to a similar extent following biphasic kinetics characterized by a fast and a slow component. Importantly, inactivation of DNA-dependent protein kinase (DNA-PK) by wortmannin generates similar shifts from the fast to the slow component of rejoining in BRCA2-proficient and BRCA2-deficient cells. This suggests that the functioning of either the fast, DNA-PK-dependent component or the slow, DNA-PK-independent component of rejoining is not affected by mutations in BRCA2. Also, a human breast cancer cell line with mutated BRCA1 shows normal rejoining of IR-induced DNA DSBs and levels of inhibition by wortmannin commensurate with the degree of DNA-PK inhibition. These observations fail to confirm a direct role for BRCA1 or BRCA2 in the rejoining of IR-induced DSBs in the genome of human tumor cells and, as a result, an involvement in nonhomologous end-joining. They are in line with similar observations with mutants deficient in genes implicated in homologous recombination and support the view that the radiosensitivity to killing of cells deficient in BRCA1 or BRCA2 derives from defects in this repair pathway.

Brca1 Facilitates Microhomology-Mediated End Joining of Dna Double Strand Breaks

Deficient Nonhomologous End-Joining Activity in Cell-Free Extracts from Brca1-null Fibroblasts.

BRCA1 and homologous recombination: implications from mouse embryonic development

53bp1 Inhibits Homologous Recombination In Brca1-Deficient Cells By Blocking Resection Of Dna Breaks

Hypersensitivity of Brca1-Deficient Mef to the Dna Interstrand Crosslinking Agent Mitomycin C is Associated with Defect in Homologous Recombination Repair and Aberrant S-Phase Arrest

53BP1 promotes microhomology-mediated end-joining in G1-phase cells.

BRCA1: a Key Player at Multiple Stages of Homologous Recombination in DNA Double-Strand Break Repair

Deficiency of Human BRCA2 Leads to Impaired Homologous Recombination but Maintains Normal Nonhomologous End Joining

BRCA1 and CtIP suppress long-tract gene conversion between sister chromatids

Association of BRCA1 with the Hrad50-Hmre11-p95 Complex and the DNA Damage Response

Cell Cycle-dependent Complex Formation of BRCA1·CtIP·MRN is Important for DNA Double-strand Break Repair

Nonhomologous End-Joining of Ionizing Radiation-Induced DNA Double-Stranded Breaks in Human Tumor Cells Deficient in BRCA1 or BRCA2.

BRIT1/MCPH1 Is Essential for Mitotic and Meiotic Recombination DNA Repair and Maintaining Genomic Stability in Mice

Molecular Functions of BRCA1 in the DNA Damage Response

BRCA 1 and CtIP suppress long tract gene conversion

The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells

Homologous Recombination is Independently Regulated by BRCA1 and P53

BRCA2 Antagonizes Classical and Alternative Nonhomologous End-Joining to Prevent Gross Genomic Instability

BRCA1 Interaction with Non-Canonical DNA Structures: Insights into Genome Maintenance and Disease Mechanisms

RAP80-directed Tuning of BRCA1 Homologous Recombination Function at Ionizing Radiation-Induced Nuclear Foci.

53BP1 Loss Rescues Embryonic Lethality but Not Genomic Instability of BRCA1 Total Knockout Mice